Remove Doctors Remove FDA Approval Remove Nurses
article thumbnail

Topical Gene Therapy FDA-Approved for Severe Skin Disease, Dystrophic Epidermolysis Bullosa

PLOS: DNA Science

The newest FDA-approved gene therapy treats the severe, skin-peeling condition dystrophic epidermolysis bullosa (DEB). The gene treatment has been a long time coming, but it differs from the handful of other approved gene therapies: it isn’t a one-and-done. Earlier results were published in Nature Medicine.

article thumbnail

Dentitox Pro – Text Presentation

The Pharma Data

The product is made here, in the USA, in our FDA approved and GMP certified facility, under sterile, strict and precise standards. For questions or concerns about any medical conditions you may have, please contact your doctor. Dentitox Pro is non-GMO and safe.

article thumbnail

FDA Set to Approve Pfizer’s COVID Vaccine

The Pharma Data

Food and Drug Administration is expected to approve emergency use of Pfizer’s coronavirus vaccine as early as Saturday after its advisory panel cleared the way for the start of a national campaign to inoculate Americans and stem the spread of COVID-19. Doctors say this reflects India’s younger and leaner population.

Vaccine 52
article thumbnail

DermaPrime

The Pharma Data

Every capsule is made here, in the USA, in our FDA approved and GMP certified facility, under sterile, strict and precise standards. For questions or concerns about any medical conditions you may have, please contact your doctor. DermaPrime Plus capsules are non-GMO and safe.

article thumbnail

The Long Road to End Tuberculosis

Codon

Based on early successes in animal experiments, doctors tested the vaccine on an infant whose mother had died of TB shortly after giving birth. These challenges have led to strategies such as directly observed therapy (DOT), in which nurses or physicians monitor patients to ensure they take their medicine every day.

Vaccine 83
article thumbnail

FDA Approves Emergency Use of Pfizer’s COVID Vaccine

The Pharma Data

Health care workers and nursing home residents and staff should get the initial shots, according to guidelines issued recently by a U.S. The nursing home industry applauded the approval. The association represents 14,000 nursing homes and assisted living facilities. ” Who is first in line to be vaccinated?

Vaccine 52
article thumbnail

IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemia (CLL) Phase 3 GLOW Study

The Pharma Data

IMBRUVICA is the only FDA-approved medicine in WM and cGVHD. IMBRUVICA was one of the first medicines to receive FDA approval via the Breakthrough Therapy Designation pathway. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.